vs

Side-by-side financial comparison of FRANKLIN FINANCIAL SERVICES CORP (FRAF) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

FRANKLIN FINANCIAL SERVICES CORP is the larger business by last-quarter revenue ($23.3M vs $14.7M, roughly 1.6× IRIDEX CORP). On growth, FRANKLIN FINANCIAL SERVICES CORP posted the faster year-over-year revenue change (51.5% vs -69.7%). Over the past eight quarters, FRANKLIN FINANCIAL SERVICES CORP's revenue compounded faster (14.6% CAGR vs 11.9%).

Franklin Financial Services Corp (Pennsylvania) is a U.S. regional bank holding company primarily operating across Pennsylvania. It provides comprehensive retail and commercial banking services, including deposit products, personal and business loans, mortgage financing, and wealth management solutions for individual consumers, small local businesses and regional institutional clients.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

FRAF vs IRIX — Head-to-Head

Bigger by revenue
FRAF
FRAF
1.6× larger
FRAF
$23.3M
$14.7M
IRIX
Growing faster (revenue YoY)
FRAF
FRAF
+121.2% gap
FRAF
51.5%
-69.7%
IRIX
Faster 2-yr revenue CAGR
FRAF
FRAF
Annualised
FRAF
14.6%
11.9%
IRIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FRAF
FRAF
IRIX
IRIX
Revenue
$23.3M
$14.7M
Net Profit
$6.0M
Gross Margin
37.2%
Operating Margin
32.1%
Net Margin
25.9%
Revenue YoY
51.5%
-69.7%
Net Profit YoY
1140.7%
EPS (diluted)
$1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRAF
FRAF
IRIX
IRIX
Q4 25
$23.3M
$14.7M
Q3 25
$23.0M
$12.5M
Q2 25
$22.3M
$13.6M
Q1 25
$20.2M
$11.9M
Q4 24
$15.4M
$12.7M
Q3 24
$19.5M
$11.6M
Q2 24
$18.6M
$12.6M
Q1 24
$17.7M
$11.8M
Net Profit
FRAF
FRAF
IRIX
IRIX
Q4 25
$6.0M
Q3 25
$5.4M
$-1.6M
Q2 25
$5.9M
$-994.0K
Q1 25
$3.9M
$-1.7M
Q4 24
$487.0K
$-834.0K
Q3 24
$4.2M
$-1.9M
Q2 24
$3.0M
$-2.7M
Q1 24
$3.4M
$-3.5M
Gross Margin
FRAF
FRAF
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
FRAF
FRAF
IRIX
IRIX
Q4 25
32.1%
Q3 25
28.9%
-11.3%
Q2 25
32.8%
-6.9%
Q1 25
23.9%
-1.7%
Q4 24
3.4%
-3.9%
Q3 24
26.2%
-16.1%
Q2 24
19.8%
-20.9%
Q1 24
22.6%
-28.0%
Net Margin
FRAF
FRAF
IRIX
IRIX
Q4 25
25.9%
Q3 25
23.3%
-12.6%
Q2 25
26.4%
-7.3%
Q1 25
19.4%
-14.2%
Q4 24
3.2%
-6.6%
Q3 24
21.6%
-16.7%
Q2 24
16.3%
-21.2%
Q1 24
18.9%
-29.5%
EPS (diluted)
FRAF
FRAF
IRIX
IRIX
Q4 25
$1.35
Q3 25
$1.19
$-0.09
Q2 25
$1.32
$-0.06
Q1 25
$0.88
$-0.10
Q4 24
$0.13
$-0.05
Q3 24
$0.95
$-0.12
Q2 24
$0.66
$-0.16
Q1 24
$0.77
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRAF
FRAF
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$127.7M
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$175.2M
Total Assets
$2.2B
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRAF
FRAF
IRIX
IRIX
Q4 25
$127.7M
$6.0M
Q3 25
$188.1M
$5.6M
Q2 25
$207.8M
$6.8M
Q1 25
$225.0M
$7.2M
Q4 24
$203.6M
$2.4M
Q3 24
$236.3M
$3.9M
Q2 24
$179.7M
$4.1M
Q1 24
$182.6M
$5.4M
Total Debt
FRAF
FRAF
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
FRAF
FRAF
IRIX
IRIX
Q4 25
$175.2M
Q3 25
$166.3M
$4.7M
Q2 25
$157.4M
$6.1M
Q1 25
$151.4M
$852.0K
Q4 24
$144.7M
$2.1M
Q3 24
$149.9M
$2.6M
Q2 24
$136.8M
$4.2M
Q1 24
$134.2M
$6.5M
Total Assets
FRAF
FRAF
IRIX
IRIX
Q4 25
$2.2B
$29.2M
Q3 25
$2.3B
$28.4M
Q2 25
$2.3B
$31.6M
Q1 25
$2.3B
$34.2M
Q4 24
$2.2B
$29.1M
Q3 24
$2.2B
$30.2M
Q2 24
$2.0B
$31.2M
Q1 24
$2.0B
$34.1M
Debt / Equity
FRAF
FRAF
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRAF
FRAF
IRIX
IRIX
Operating Cash FlowLast quarter
$25.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRAF
FRAF
IRIX
IRIX
Q4 25
$25.4M
Q3 25
$8.3M
$-1.2M
Q2 25
$5.1M
$-397.0K
Q1 25
$8.8M
$-1.1M
Q4 24
$21.8M
$-1.2M
Q3 24
$7.8M
$-3.1M
Q2 24
$2.4M
$-1.3M
Q1 24
$7.3M
$-1.6M
Free Cash Flow
FRAF
FRAF
IRIX
IRIX
Q4 25
Q3 25
$-1.2M
Q2 25
$-410.0K
Q1 25
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-1.7M
FCF Margin
FRAF
FRAF
IRIX
IRIX
Q4 25
Q3 25
-9.4%
Q2 25
-3.0%
Q1 25
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-14.0%
Capex Intensity
FRAF
FRAF
IRIX
IRIX
Q4 25
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
FRAF
FRAF
IRIX
IRIX
Q4 25
4.21×
Q3 25
1.55×
Q2 25
0.87×
Q1 25
2.25×
Q4 24
44.67×
Q3 24
1.85×
Q2 24
0.80×
Q1 24
2.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons